from the Innovative Genomics Institute
This July, UCSF's Alex Marson and his team published a unique method to reprogram human T cells with CRISPR technology. This video breaks down the key points of their method and how these new advancements could lead to treatments for cancer and autoimmune diseases. Follow these links to read the full paper and the UCSF Press Release.
This video was created by the science communication team at the Innovative Genomics Institute at the University of California, Berkeley.
• Learn more about CRISPR in this video from iBiology.org.
• Learn more about CAR T-Cell Immunotherapy, named the 2018 Advance of the Year by the American Society of Clinical Oncology.